Clinical Value of Endoscopic Esophageal Screening in Head and Neck Squamous Cell Carcinoma Patients
Otolaryngology–Head and Neck Surgery · 2024
DOI: 10.1002/ohn.519 ↗At a glance
Journal article in Otolaryngology–Head and Neck Surgery, 2024. Written by Wei-Chih Chen and 6 co-authors. Institution: Department of Otolaryngology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan. Major MEDLINE topics: Head and Neck Neoplasms, Carcinoma, Squamous Cell, Hypopharyngeal Neoplasms, Esophageal Neoplasms. Cited 3 times so far (Crossref); 40 references. The full text is freely available (open access, CC BY-NC-ND 4.0).
Abstract (original language)
Objective
To investigate the clinical benefit of routine esophageal screening in newly diagnosed head and neck squamous cell carcinoma (HNSCC) patients. Study Design Retrospective cohort study.
Setting
Tertiary medical center.
Methods
This retrospective study selected newly diagnosed HNSCC patients from the Chang Gung Research Database between January 2007 and December 2019. Patients who underwent endoscopic esophageal examinations within 2 months of the initial diagnosis of HNSCC were included in the screening group. The clinical outcomes of the screening and nonscreening groups were analyzed.
Results
In total, 13,627 HNSCC patients were included, comprising 1032 females and 12,640 males (mean age 55.0 years), and the esophageal screening group included 7033 (51.4%) patients. The prevalence rate of esophageal tumors was 4.5%. Hypopharyngeal cancer patients were the most likely to have (13.4%) second primary esophageal tumors. The American Joint Committee on Cancer stage of the esophageal tumor was lower in the esophageal screening group than in the nonesophageal screening group. The oral, oropharyngeal, and hypopharyngeal cancer patients in the esophageal screening group had better survival outcomes than their counterparts in the nonesophageal screening group.
Conclusion
Endoscopic esophageal screening of newly diagnosed HNSCC patients can detect esophageal tumors at an early stage and improve overall survival. Esophageal screening could be a routine survey in HNSCC patients, particularly those with lifestyle risk factors and in countries with a high prevalence of esophageal cancer.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Otolaryngology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan.
- Department of Post-Baccalaureate Medicine, National Sun Yat-Sen University, Kaohsiung, Taiwan.
- Department of Public Health, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
- Department of Radiation Oncology & Proton and Radiation Therapy Center, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan.
- School of Traditional Chinese Medicine, College of Medicine, Chang Gung University, Taoyuan, Taiwan.
- Department of Hematology-Oncology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan.
ORCID profiles: Wei-Chih Chen, Yao-Hsu Yang
Cite
APA
Chen, W. C., Wu, C. N., Wang, Y. M., Chiu, T. J., Wu, S. C., Yang, Y. H., & Luo, S. D. (2024). Clinical Value of Endoscopic Esophageal Screening in Head and Neck Squamous Cell Carcinoma Patients. Otolaryngology–Head and Neck Surgery. https://doi.org/10.1002/ohn.519
Vancouver
Chen WC, Wu CN, Wang YM, Chiu TJ, Wu SC, Yang YH, et al. Clinical Value of Endoscopic Esophageal Screening in Head and Neck Squamous Cell Carcinoma Patients. Otolaryngology–Head and Neck Surgery. 2024. doi:10.1002/ohn.519
BibTeX
@article{Chen2024,
author = {Chen, Wei-Chih and Wu, Ching-Nung and Wang, Yu-Ming and Chiu, Tai-Jan and Wu, Shao-Chun and Yang, Yao-Hsu and Luo, Sheng-Dean},
title = {Clinical Value of Endoscopic Esophageal Screening in Head and Neck Squamous Cell Carcinoma Patients},
journal = {Otolaryngology–Head and Neck Surgery},
year = {2024},
doi = {10.1002/ohn.519}
}
EUVIMED